Patent · US Active

Small-molecule botulinum toxin inhibitors

US8404728B2 · kind B2 · utility

0Cited by
55References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 29, 2010
Grant dateMar 26, 2013
Priority date—
Expiry dateMar 10, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16C20/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure relates to materials and methods for inhibiting Botulinum neurotoxin, and more particularly to materials and methods for inhibiting the zinc endopeptidase of Botulinum neurotoxin serotypes A, D and/or E (BoNTA, BoNTD and/or BoNTE).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.